Skip to main contentAI and Advanced
/
SURAKSHA · NSEMarket ticker unavailable · configure an authorised index feed
SU
NSE · Equity shares · Healthcare Facilities7.50 · 2.30%
Suraksha Diagnostic SURAKSHA
NSE:INR 334
BSE:INR 259.5
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for SURAKSHA
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 326.5
Day rangeINR 300 — INR 334
52-week rangeINR 224.1 — INR 349
Volume98,905
Market cap1,355.14
P/E36.89
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)310.41
Net Income (INR Cr)32.19
P/E Ratio36.89
Book Value45.7
EPS6.18
Price/BV7.31Computed
Research path: Interpret Suraksha Diagnostic's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
SURAKSHASuraksha Diagnostic1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 448.12 | 333.52 | 300.21 |
| Cash Equivalents | 3.21 | Not available | Not available |
| Other Liabilities Total | 22.7 | 1.02 | 0.77 |
| Long Term Debt | 0.18 | 2.88 | 5.18 |
| Common Stock Total | 10.42 | 10.42 | 8.53 |
| Other Equity Total | 234.43 | Not available | Not available |
| Other Current Assets Total | 4.64 | 3.14 | Not available |
| Total Assets | 448.12 | 333.52 | 300.21 |
| Current Portof LT Debt/Capital Leases | 16.05 | 14.79 | 14.99 |
| Total Equity | 244.85 | 211.24 | 179.41 |
| Long Term Investments | 21.62 | 36.5 | 8.45 |
| Total Common Shares Outstanding | 5.21 | 5.21 | 5.21 |
| Tangible Book Valueper Share Common Eq | 45.7 | 40.18 | 34.24 |
| Goodwill Net | 3.88 | Not available | Not available |
| Total Liabilities | 203.27 | 122.28 | 120.8 |
| Total Debt | 130.34 | 88.89 | 90.48 |
| Short Term Investments | 23.82 | 15.8 | 52.5 |
| Cashand Short Term Investments | 27.04 | 18.04 | 55.02 |
| Total Receivables Net | 22.76 | 15.31 | 8.88 |
| Deferred Income Tax | 8 | 5.45 | 5.39 |
| Accounts Receivable-Trade Net | 22.76 | 13.63 | 8.88 |
| Property/Plant/Equipment Total-Net | 344.75 | 231.53 | 211.77 |
| Minority Interest | -1.37 | -1.01 | -0.26 |
| Total Current Liabilities | 59.65 | 42.72 | 39.41 |
| Total Inventory | 8.14 | 9.2 | 7.92 |
| Accounts Payable | 20.86 | 13.64 | 14.39 |
| Other Currentliabilities Total | 22.74 | 9.54 | 6.21 |
| Total Long Term Debt | 114.29 | 74.1 | 75.49 |
| Intangibles Net | 2.95 | 1.99 | 1.08 |
| Note Receivable-Long Term | 12.34 | 9.16 | 6.46 |
| Total Current Assets | 62.58 | 47.15 | 72.45 |
| Capital Lease Obligations | 114.11 | 71.23 | 70.31 |
| Accumulated Depreciation Total | Not available | -95.04 | -61.66 |
| Accrued Expenses | Not available | 4.75 | 3.83 |
| Prepaid Expenses | Not available | 1.45 | 0.62 |
| Additional Paid-In Capital | Not available | 46.48 | 48.37 |
| Cash | Not available | 2.25 | 2.52 |
| Retained Earnings(Accumulated Deficit) | Not available | 154.34 | 122.51 |
| Property/Plant/Equipment Total-Gross | Not available | 316.47 | 272.12 |
| Notes Payable/Short Term Debt | Not available | 0 | 0 |
| Other Long Term Assets Total | Not available | 7.19 | Not available |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio0.6
Price to Sale Ratio4.37
Margins
Operating Margin 12m17.38
Net Profit Margin 12m10.12
Yield
Dividend Yield %0.19
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk33.72
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,913 | 1.28 L | 64.93 | — |
| Max Healthcare Institute | INR 1,087.15 | 1.06 L | 71.47 | — |
| Fortis Healthcare | INR 955.6 | 72,073.21 | 67.89 | — |
| Aster DM Healthcare | INR 800.1 | 41,214 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,973.1 | 40,165.51 | 48.07 | — |
Shareholding
Ownership
- Promoter
- 49.10%
- FII
- 13.47%
- MF
- 20.05%
- Other
- 17.38%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Suraksha Diagnostic share price dips after discounted listing. Buy, sell or hold?Market news · 6 Dec 2024, 2:27 pm
Stock market today: Suraksha Diagnostic's share price opened on the BSE at ₹ 437 apiece, while it opened on the NSE at ₹ 438 per share
Suraksha Diagnostic shares make tepid debut on Dalal Street, list flat at <span class='webrupee'>₹</span>438Market news · 6 Dec 2024, 10:03 am
Suraksha Diagnostic had a muted debut on Dalal Street on Friday, December 06, with its shares listing at ₹ 438 each on the NSE, marking a 0.68% lower over the issue price of ₹ 441. On the BSE, the stock opened at ₹ 437.
Suraksha Diagnostic IPO share listing date today. Here's what GMP, experts signalMarket news · 6 Dec 2024, 6:39 am
Suraksha Diagnostic IPO listing date is today, December 6. Suraksha Diagnostic shares will be listed on both the stock exchanges - BSE and NSE.
Suraksha Diagnostic IPO listing tomorrow: Here’s what GMP, subscription status, expert signal ahead of listingMarket news · 5 Dec 2024, 4:22 pm
Suraksha Diagnostic IPO listing is set for December 6, with share allocation completed and credits occurring today. The IPO saw strong demand, particularly from QIBs and NIIs, and is anticipated to list at ₹ 454, reflecting a ₹ 13 premium in the grey market.
Suraksha Diagnostic IPO allotment finalised today; latest GMP, step-by-step guide to check statusMarket news · 4 Dec 2024, 10:21 pm
Suraksha Diagnostic IPO allotment has been finalised today, with investors able to check status on Kfin Technologies Ltd's portal. The IPO subscription ended with a decent response from various investors. Refunds for unallocated shares begin on December 5, with shares allocated on the same day.
Suraksha Diagnostic IPO subscribed 1.27 times on Day 3; Check GMP, subscription status, other detailsMarket news · 3 Dec 2024, 9:05 pm
Suraksha Diagnostic IPO received a positive response at the end of the Day 3 of public subscription. The public offer is set to be listed on the domestic stock market on Friday, December 6.
Corporate actions
Events
- dividendRs.0.5000 per share(25%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
Rusaka Markets Community
Discussion and sentiment for Suraksha Diagnostic
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Suraksha Diagnostic Limited is an India-based company. The Company is primarily engaged in the business of running diagnostic centers for carrying out various pathological and radiological services. The Company offers integrated solutions for pathology and radiology testing, and medical consultation services to its customers through its operational network. Its services include Imaging, Neurology, Cardiology, Gastroenterology, and Pathology. Its Imaging services include X-Ray, DEXA scan, USG scan, CT scan and others. Its Neurology services include EEG, EMG, NCV. Its Cardiology services include Echocardiogram Test, Stress Test / Treadmill Test, Holter Monitoring, Color Doppler, Peripheral Doppler, and others. Its Pathology services include Microbiology, Cytogenetic, Serology, Molecular Biology, Histopathology, Cytopathology, Haematology, and others. Its Gastroenterology services include Upper GI Endoscopy, Sigmoidoscopy, Colonoscopy, Proctoscopy, Proctosigmoidoscopy, and others.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- SURAKSHA
- BSE Code
- 544293
Questions
Stock FAQ
What is the symbol and ISIN of Suraksha Diagnostic?
Suraksha Diagnostic has the symbol SURAKSHA and ISIN - INE877V01027.
What is the current price of Suraksha Diagnostic?
Suraksha Diagnostic is currently trading at INR 334.00.
What are the year high and year low of Suraksha Diagnostic?
Suraksha Diagnostic has a year high of INR 349.00 and a year low of INR 224.10.
What is the market capitalization of Suraksha Diagnostic?
Suraksha Diagnostic has a market capitalization of INR 1,355.14 crore.
What is the P/E ratio of Suraksha Diagnostic?
Suraksha Diagnostic has a P/E ratio of 36.89.
What is the dividend yield of Suraksha Diagnostic?
Suraksha Diagnostic has a dividend yield of 0.19%.
How is the financial performance of Suraksha Diagnostic based on revenue, net income, and EPS?
Suraksha Diagnostic has revenue of INR 310.41 crore, net income of INR 32.19 crore, and EPS of INR 6.18.
What is the book value of Suraksha Diagnostic?
Suraksha Diagnostic has a book value of INR 45.70.
What is the debt-to-equity ratio of Suraksha Diagnostic?
Suraksha Diagnostic has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Suraksha Diagnostic?
Suraksha Diagnostic has a price-to-book ratio of 7.31 and a price-to-sales ratio of 4.37.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.